Monogram Technologies Inc. (MGRM)

Data as of Oct 7, 2025, from SEC Form 4 filings.

No open-market insider trades (90d)Watch MGRM

See up to 3 months of MGRM. The 7-day demo opens the 1M and 3M ranges and puts MGRM on your watchlist.

Latest MGRM insider trades

Colleen Gray - Director
Derivative8,000 sh
Oct 7, 2025
Douglas Unis - Director
Derivative3,532,622 sh
Oct 7, 2025
Douglas Unis - Director

About Monogram Technologies Inc. (MGRM)

Monogram Technologies Inc. files with the SEC under CIK 0001769759 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for MGRM on EDGAR

MGRM Form 4 activity by transaction type, last 90 days

No Form 4 activity for MGRM in the last 90 days.

MGRM insider transactions (Form 4)

15 Form 4 filings on record, the earliest from Nov 26, 2024, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Oct 7, 2025	Colleen Gray - Director	Derivative	Stock Option	8,000	-^{footnote F1,F2}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR
Oct 7, 2025	Douglas Unis - Director	Derivative	Common Stock	3,532,622	-^{footnote F1,F2}	-
Oct 7, 2025	Douglas Unis - Director	Derivative	Stock Option	1,475,000	-^{footnote F1,F3}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR
Oct 7, 2025	Kamran Shamaei - Officer	Derivative	Common Stock	2,926	-^{footnote F1,F2}	-
Oct 7, 2025	Kamran Shamaei - Officer	Derivative	Stock Option	1,310,000	-^{footnote F1,F3}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR
Oct 7, 2025	Benjamin Sexson - Officer	Derivative	Common Stock	4,006,330	-^{footnote F1,F2}	-
Oct 7, 2025	Benjamin Sexson - Officer	Derivative	Stock Option	1,560,000	-^{footnote F1,F3}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR
Oct 7, 2025	Noel Knape - Officer	Derivative	Common Stock	296,385	-^{footnote F1,F2}	-
Oct 7, 2025	Noel Knape - Officer	Derivative	Stock Option	115,000	-^{footnote F1,F3}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR
Oct 7, 2025	Kirk Richard Lee van Jr. - Director	Derivative	Stock Option	7,000	-^{footnote F1,F2}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR
Oct 7, 2025	Paul H. Riss - Director	Derivative	Stock Option	40,000	-^{footnote F1,F2}	-
Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR
Jan 8, 2025	Douglas Unis - Director	Grant or award	Stock Option	35,000	-	-
Jan 8, 2025	Kamran Shamaei - Officer	Grant or award	Stock Option	250,000	-	-
Jan 8, 2025	Benjamin Sexson - Officer	Grant or award	Stock Option	160,000	-	-
Jan 8, 2025	Noel Knape - Officer	Grant or award	Stock Option	40,000	-	-
Jan 8, 2025	Kirk Richard Lee van Jr. - Director	Grant or award	Stock Option	5,000	-	-
Jan 8, 2025	Paul H. Riss - Director	Grant or award	Stock Option	10,000	-	-
Jan 8, 2025	Colleen Gray - Director	Grant or award	Stock Option	5,000	-	-
Nov 25, 2024	Noel Knape - Officer	Grant or award	Common Stock	288,461	$2.08	$600K

MGRM insider trading FAQ

What is the latest insider trade for MGRM?

Monogram Technologies Inc. (MGRM) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-10-07. The full record for MGRM runs to 15 Form 4 filings, the earliest from 2024-11-26. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying MGRM stock?

No insider purchases of MGRM were filed in the last 90 days.

How many insiders are selling MGRM stock?

No insider sales of MGRM were filed in the last 90 days.

Where can I see MGRM SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects MGRM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 7, 2025 - Colleen Gray view on EDGAR
Oct 7, 2025 - Douglas Unis view on EDGAR
Oct 7, 2025 - Kamran Shamaei view on EDGAR
Oct 7, 2025 - Benjamin Sexson view on EDGAR
Oct 7, 2025 - Noel Knape view on EDGAR
Oct 7, 2025 - Kirk Richard Lee van Jr. view on EDGAR
Oct 7, 2025 - Paul H. Riss view on EDGAR
Jan 8, 2025 - Douglas Unis view on EDGAR
Jan 8, 2025 - Kamran Shamaei view on EDGAR
Jan 8, 2025 - Benjamin Sexson view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where MGRM's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow MGRM with a 7-day demo

MGRM on your watchlist
Every MGRM Form 4 filing on record
Up to 3 months of MGRM price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Oct 7, 2025

Colleen Gray - Director

Derivative

Stock Option

8,000

-^{footnote F1,F2}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR

Oct 7, 2025

Douglas Unis - Director

Derivative

Common Stock

3,532,622

-^{footnote F1,F2}

Oct 7, 2025

Douglas Unis - Director

Derivative

Stock Option

1,475,000

-^{footnote F1,F3}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR

Oct 7, 2025

Kamran Shamaei - Officer

Derivative

Common Stock

2,926

-^{footnote F1,F2}

Oct 7, 2025

Kamran Shamaei - Officer

Derivative

Stock Option

1,310,000

-^{footnote F1,F3}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR

Oct 7, 2025

Benjamin Sexson - Officer

Derivative

Common Stock

4,006,330

-^{footnote F1,F2}

Oct 7, 2025

Benjamin Sexson - Officer

Derivative

Stock Option

1,560,000

-^{footnote F1,F3}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR

Oct 7, 2025

Noel Knape - Officer

Derivative

Common Stock

296,385

-^{footnote F1,F2}

Oct 7, 2025

Noel Knape - Officer

Derivative

Stock Option

115,000

-^{footnote F1,F3}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding share of Issuer common stock was automatically converted into the right to receive (i) $4.04 in cash, without interest and subject to applicable withholding taxes (the "Cash Amount") and (ii) one contractual contingent value right ("CVR")… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) Cash Amount over (B) the exercise price per share of such option, and (ii) one CVR… Full note on SEC EDGAR

Oct 7, 2025

Kirk Richard Lee van Jr. - Director

Derivative

Stock Option

7,000

-^{footnote F1,F2}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR

Oct 7, 2025

Paul H. Riss - Director

Derivative

Stock Option

40,000

-^{footnote F1,F2}

Footnote F1 (price): In connection with the terms of an Agreement and Plan of Merger, dated July 11, 2025 (the "Original Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., ("Zimmer Biomet"), and Honey Badger Merger Sub, Inc., a wholly owned subsidiary of Zimmer Biomet… Full note on SEC EDGAR
Footnote F2 (price): At the Effective Time, each outstanding and unexercised option, whether or not vested, was cancelled and converted into the right to receive, (i) a cash payment equal to the excess of (A) $4.04 (the "Cash Amount") over (B) the exercise price per share of such option, and (ii)… Full note on SEC EDGAR